Key result
Scorpion venom active fractions target voltage-gated ion channels and may have profound effects on excitable cells, highlighting their potential in future drug development.
Why the study?
Elucidating the cellular and electrophysiological impacts of scorpion toxins that target voltage-gated ion channels in excitable cells could aid future drug development.
Scorpion venom fractions may have electrophysiological impacts on excitable cells by targeting voltage-gated ion channels, offering potential for future drug development.
Scorpion toxin studies may guide ion channel drug design; leaves open clinical translation pending targeted trials.
It is a long time that natural toxin research is conducted to unlock the medical potential of toxins. Although venoms-toxins cause pathophysiological conditions, they may be effective to treat several diseases. Since toxins including scorpion toxins target voltagegated ion channels, they may have profound effects on excitable cells. Therefore, elucidating the cellular and electrophysiological impacts of toxins, particularly scorpion toxins would be helpful in future drug development opportunities.
No takes yet. Share an insight, caveat, or question.
Tamadon et al. (2019) studied this question. Scorpion venom active fractions was evaluated. Scorpion venom active fractions target voltage-gated ion channels and may have profound effects on excitable cells, highlighting their potential in future drug development.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: